Hemoglobin as a biomarker for melanoma - short report DOI: 10.13140/RG.2.2.32520.29445, ISSN 2753-8176 (online)
Hemoglobin as a biomarker for melanoma - short report Ana Pedro (1) 1. Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway,Chester CH4 9QR, United Kingdom anapedrolaboratories@gmail.com Introduction Anemia is a common condition within cancer patients affecting their survival (1). In cutaneous melanoma (CM), low blood hemoglobin concentration is associated with nodal involvement and metastatic disease. Although anemia in diagnosis is not an independent prognostic factor for survival in CM, it is associated with poor prognostic factors (2). Also, the interstitial fluid and the deriving lymph are in direct contact with the cellular layer of each organ. Therefore, the analysis of the composition of the lymphatic fluid may provide precise pathological biochemical and cellular information about an organ including the skin (3). For these reasons, we collected lymphatic fluid samples both from healthy patients and CM patients suffering from different stages...